U.S. federal trademark · Serial No. 90555777 · Reg. No. 7295072
Biological preparations for gene therapy, namely, the treatment of Huntington's disease, Gaucher Disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, Huntington's disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease; treatments for neurological diseases via gene replacement or gene knockdown, namely, the treatment of Huntington's disease, Gaucher Disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, neurodegenerative disease, and Parkinson's disease
Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring information about medical research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.